Skip to main content
. Author manuscript; available in PMC: 2014 Jun 9.
Published in final edited form as: J Biol Chem. 2007 Aug 18;282(44):31964–31971. doi: 10.1074/jbc.M705440200

Fig. 2.

Fig. 2

Structure of the substrate analogues heptaprenyl-Lipid II (1a) and heptaprenyl-Lipid IV (2a). Radiolabeled Lipid II (1b) is made chemoenzymatically using [14C]-GlcNAc as described in (20). Alternatively, an acetyl group can be incorporated on the lysines of the substrate peptide chains, with no effect on substrate utility, by treatment with 14C-acetic anhydride to give (1c) or 14C-acetic anhydride to give radiolabeled (2b) as described in (21).